Marksans Pharma has received the US health regulator‘s approval for loratadine liquid filled capsules that are used in treating allergies, in the American market.

Marksans Pharma has said in a BSE filing that ” USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg.”

The Loratadine liquid-filled capsules are therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC.

Read EquityPandit’s Nifty Pharma Outlook for this week